169 related articles for article (PubMed ID: 16299455)
41. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma.
Mariette C; Piessen G; Lamblin A; Mirabel X; Adenis A; Triboulet JP
Br J Surg; 2006 Sep; 93(9):1077-83. PubMed ID: 16779882
[TBL] [Abstract][Full Text] [Related]
42. Intraoperative pathological investigation of recurrent nerve nodal metastasis can guide the decision whether to perform cervical lymph node dissection in thoracic esophageal cancer.
Ueda Y; Shiozaki A; Itoi H; Okamoto K; Fujiwara H; Ichikawa D; Kikuchi S; Fuji N; Itoh T; Ochiai T; Komatsu S; Yamagishi H
Oncol Rep; 2006 Nov; 16(5):1061-6. PubMed ID: 17016593
[TBL] [Abstract][Full Text] [Related]
43. Predeposit autologous plasma donation in liver resection for hepatocellular carcinoma: toward allogenic blood-free operations.
Ishizawa T; Hasegawa K; Tsuno NH; Tanaka M; Mise Y; Aoki T; Imamura H; Beck Y; Sugawara Y; Makuuchi M; Takahashi K; Kokudo N
J Am Coll Surg; 2009 Aug; 209(2):206-14. PubMed ID: 19632597
[TBL] [Abstract][Full Text] [Related]
44. Preoperative prediction of the occurrence and severity of complications after esophagectomy for cancer with use of a nomogram.
Lagarde SM; Reitsma JB; Maris AK; van Berge Henegouwen MI; Busch OR; Obertop H; Zwinderman AH; van Lanschot JJ
Ann Thorac Surg; 2008 Jun; 85(6):1938-45. PubMed ID: 18498798
[TBL] [Abstract][Full Text] [Related]
45. Esophagectomy in patients aged over 80 years with esophageal cancer.
Takeno S; Takahashi Y; Watanabe S; Ono K; Kamei M; Yamashita S; Kawahara K
Hepatogastroenterology; 2008; 55(82-83):453-6. PubMed ID: 18613386
[TBL] [Abstract][Full Text] [Related]
46. Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: a retrospective study.
Sugita S; Sasaki A; Iwaki K; Uchida H; Kai S; Shibata K; Ohta M; Kitano S
Eur J Surg Oncol; 2008 Mar; 34(3):339-45. PubMed ID: 17400417
[TBL] [Abstract][Full Text] [Related]
47. A prospective trial for avoiding cervical lymph node dissection for thoracic esophageal cancers, based on intra-operative genetic diagnosis of micrometastasis in recurrent laryngeal nerve chain nodes.
Miyata H; Yano M; Doki Y; Yasuda T; Yoshioka S; Sugita Y; Takiguchi S; Fujiwara Y; Monden M
J Surg Oncol; 2006 May; 93(6):477-84. PubMed ID: 16615150
[TBL] [Abstract][Full Text] [Related]
48. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer.
Sujendran V; Wheeler J; Baron R; Warren BF; Maynard N
Br J Surg; 2008 Feb; 95(2):191-4. PubMed ID: 17948302
[TBL] [Abstract][Full Text] [Related]
49. [The local control of radiotherapy following Ivor-Lewis esophagectomy in the patients with stage II A middle-third thoracic esophageal cancer].
Zhang MY; Wang Z; Liu XY; Chen G; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(14):1048-50. PubMed ID: 19094527
[TBL] [Abstract][Full Text] [Related]
50. Effect of perioperative blood transfusion on prostate cancer recurrence.
Ford BS; Sharma S; Rezaishiraz H; Huben RS; Mohler JL
Urol Oncol; 2008; 26(4):364-7. PubMed ID: 18367097
[TBL] [Abstract][Full Text] [Related]
51. The effects of perioperative blood transfusion on morbidity and mortality after esophagectomy.
Fields RC; Meyers BF
Thorac Surg Clin; 2006 Feb; 16(1):75-86. PubMed ID: 16696285
[TBL] [Abstract][Full Text] [Related]
52. Outcomes after oesophagogastrectomy for carcinoma of the oesophagus.
Omundsen M; Babor R; Johnston P
ANZ J Surg; 2007; 77(1-2):37-9. PubMed ID: 17295818
[TBL] [Abstract][Full Text] [Related]
53. Surgical outcome of patients with thoracic esophageal cancer positive for cervical lymph nodes.
Shimada H; Shiratori T; Okazumi S; Matsubara H; Nabeya Y; Shuto K; Shimizu T; Hayashi H; Ochiai T
Hepatogastroenterology; 2007; 54(73):100-3. PubMed ID: 17419240
[TBL] [Abstract][Full Text] [Related]
54. Squamous cell carcinoma-antigen messenger RNA level in peripheral blood predicts recurrence after resection in patients with esophageal squamous cell carcinoma.
Honma H; Kanda T; Ito H; Wakai T; Nakagawa S; Ohashi M; Koyama Y; Valera VA; Akazawa K; Hatakeyama K
Surgery; 2006 May; 139(5):678-85. PubMed ID: 16701102
[TBL] [Abstract][Full Text] [Related]
55. Comparison of efficacy of regional and extensive clinical target volumes in postoperative radiotherapy for esophageal squamous cell carcinoma.
Qiao XY; Wang W; Zhou ZG; Gao XS; Chang JY
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):396-402. PubMed ID: 17855004
[TBL] [Abstract][Full Text] [Related]
56. [Use of post-operative drainage and auto-transfusion sets in total knee arthroplasty].
Hendrych J
Acta Chir Orthop Traumatol Cech; 2006; 73(1):34-8. PubMed ID: 16613746
[TBL] [Abstract][Full Text] [Related]
57. Robot-assisted thoracoscopic oesophagectomy for cancer.
Boone J; Schipper ME; Moojen WA; Borel Rinkes IH; Cromheecke GJ; van Hillegersberg R
Br J Surg; 2009 Aug; 96(8):878-86. PubMed ID: 19591168
[TBL] [Abstract][Full Text] [Related]
58. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].
von Rahden BH; Feith M; Stein HJ
Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774
[TBL] [Abstract][Full Text] [Related]
59. Prognostic and clinical evaluation of axillary lymph node metastasis in esophageal cancer.
Komatsu S; Ueda Y; Ichikawa D; Fujiwara H; Okamoto K; Kikuchi S; Shiozaki A; Imura K; Ohsawa R; Ochiai T; Tsubokura T; Yamagishi H
Jpn J Clin Oncol; 2007 Apr; 37(4):314-8. PubMed ID: 17553821
[TBL] [Abstract][Full Text] [Related]
60. Minimally invasive esophagectomy for stage I and II esophageal cancer.
Yamamoto S; Kawahara K; Maekawa T; Shiraishi T; Shirakusa T
Ann Thorac Surg; 2005 Dec; 80(6):2070-5. PubMed ID: 16305846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
